News & Press Releases

Mintz has further enhanced its high-powered litigation practice with a five-partner team led by Philip Iovieno and including Nicholas Gravante, Jr., Sean O’Shea, Michael Petrella, and Matthew Karlan. 

Member Joanne Hawana was quoted in a Reuters article about the FDA’s plans to restrict GLP-1 ingredients in non-approved compound drugs. The article reports on the agency’s potential enforcement actions involving Hims & Hers and broader regulatory scrutiny of compounded weight-loss medications.

The National Law Journal highlighted the addition of Robert Vlasis to Mintz. He joins as a Co-chair of the firm’s International Trade Commission practice, further strengthening the firm's intellectual property services.

Mintz is pleased to have represented Boothby Therapy Services, New Hampshire’s leading provider of speech therapy, occupational therapy, school psychology, vision, orientation, and mobility, on its acquisition by Point Quest Group, a national provider of special education services, training, and program management. The Mintz deal team was led by Mergers & Acquisitions Practice Co-chair Dean Zioze and Associate Troy Nichols.

Member Theresa Carnegie shared insights in a Law360 Healthcare Authority article about a federal government bulletin stating that drug manufacturers will be able to sell medications directly to patients through TrumpRx, without violating federal anti-kickback laws. The article sheds light on the potential legal risks associated with excluding telehealth providers, pharmacies, and other parties not covered by the bulletin.

Robert Vlasis has joined Mintz as Co-chair of the firm’s International Trade Commission (ITC) Practice and as a Member in its IP Litigation Practice in Washington, DC, bringing a rare breadth of ITC experience that complements the firm’s globally recognized IP capabilities.